Product Code: RP-ID-10070619 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10070619
Market Overview:
Breast Lesion Localization Methods Market Segmentation by Type (Wire Localization, Radioisotope Localization, Radioactive Seed Localization, Radio Occult Lesion Localization, Magnetic Tracers, and Others); by Biopsy Techniques (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Surgical Biopsy, Incisional Biopsy, Excisional Biopsy, Vacuum-Assisted Breast Biopsy, and Others); and by End-Users (Diagnostic Centers, Hospitals, Oncology Clinics, and Ambulatory Surgical Centers)-Global Demand Analysis & Opportunity Outlook 2031
Global Breast Lesion Localization Market Highlights Over 2022 - 2031
The global breast lesion localization market generated the revenue figure of approximately USD 520 million in the year 2021 and is estimated to grow at a CAGR of ~10% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to inactive lifestyle, growing cases of breast cancer, rising consumption of contraceptive pills, and increasing prevalence of breast disease or breast cysts. According to the Breast Cancer Organization, an estimate of 287,850 new cases of invasive breast cancer is expected to be diagnosed among women in living in U.S in 2022. Additionally, rising demand for better healthcare facility, generous reimbursement policies by government and growing awareness about early treatment for breast cancer among people are few other factors anticipated to drive the growth of the market. Also, the increasing number of breast cancer screening programs is anticipated to boost the market growth.
CLICK TO DOWNLOAD SAMPLE REPORT
Breast lesion localization is a procedure used for the detection of abnormal changes in the breast tissue, also known as breast lesion, caused due to genetic disorders, disease, or injury. The use of lesion localization devices is required in the case of breast cancer. Surgeons select methods of treatment based on a variety of parameters, including the patient's age, the average time of location, efficacy, surgery, the convenience of use, and safety. Moreover, breast screening programs encourage early diagnosis of breast cancer, which allows effective treatment.
The global breast lesion localization market is segmented based on type, biopsy technique, and end-users. On the basis of type, the market is divided into wire localization, radioisotope localization, radioactive seed localization, radio occult lesion localization, magnetic tracers, and others. Among these segments, the wire localization segment is anticipated to hold the largest market share in value in the upcoming year by growing at a moderate CAGR during the forecast period. The growth of the segment is driven by successful result in abnormal tissue localization, minimum removal of normal tissues, and reimbursement for breast lesion localization devices.
Global Breast Lesion Localization Market Regional Synopsis
Regionally, the global breast lesion localization market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region witnessed a modest growth in the year 2021. The growth of the market can be attributed to the increasing prevalence of breast cancer, presence of advanced healthcare infrastructure, and better reimbursement policies. Alternatively, the market in the Asia Pacific region is estimated to witness growth at a significant CAGR during the forecast period. The growth of the market is anticipated to be driven by the increasing cases of breast cancer, rising disposable income levels, growing clinical needs, and increasing awareness among patients regarding early diagnosis. Moreover, rapid development in healthcare infrastructure and rising demand for breast-conserving surgery are contributing to the rapid growth of the market. In the statistics given by Organization for Economic Cooperation and Development (OECD), an estimated of 839000 women was diagnosed with breast cancer whereas, over 286000 deaths were reported in the year 2018, in the Asia Pacific region.
Market Segmentation
Our in-depth analysis of the global breast lesion localization market includes the following segments:
By Type
-
Wire Localization
-
Radioisotope Localization
-
Radioactive Seed Localization
-
Radio Occult Lesion Localization
-
Magnetic Tracers
-
Others
By Biopsy Techniques
-
Fine Needle Aspiration Biopsy
-
Core Needle Biopsy
-
Surgical Biopsy
-
Incisional Biopsy
-
Excisional Biopsy
-
Vacuum-Assisted Breast Biopsy
-
Others
By End Users
-
Diagnostic Centers
-
Hospitals
-
Oncology Clinics
-
Ambulatory Surgical Centers
Growth Drivers and Challenges Impacting the Growth of the Global Breast Lesion Localization Market
Growth Drivers
-
Growing incidences of breast cancer
-
Increasing investments for research and development of monitoring devices
-
Improvement in healthcare facilities
-
Growing awareness about early diagnosis
Challenges
-
High cost of products & treatment
-
Lack of skilled professionals
Key Companies Dominating the Global Breast Lesion Localization Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global breast lesion localization market that are included in our report are MOLLI Surgical Inc., ARGON MEDICAL., Merit Medical Systems, CP Medical, STERYLAB S.r.l., Cook Group Incorporated, Becton, Dickinson, and Company (BD), Hologic, Inc., Zimmer Biomet, and PerkinElmer Inc. among others.
Latest Developments in the Global Breast Lesion Localization Market:
-
29 April 2021: The US Food and Drug Administration has approved MOLLI Surgical Inc.'s lesion localization technology, called MOLLI which is a wire-free localization system that allows radiologists to label lesions for excision during breast cancer surgery.
-
04 January 2021: Hologic, Inc., a company focused on the improvement of women’s health announced the acquisition of SOMATEX Medical Technologies GmbH. The acquisition is expected to strengthen and expand Hologic’s breast market portfolio along with the enhancement of innovative and comprehensive solutions for the breast health.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- MOLLI Surgical Inc.
- ARGON MEDICAL.
- Merit Medical Systems
- CP Medical
- STERYLAB S.r.l.
- Cook Group Incorporated
- Becton
- Dickinson,
- Hologic Inc.
- Zimmer Biomet
- PerkinElmer Inc
Related Reports
Proof of Quality & Reliability
